About Optigenex
Optigenex is a company based in Melissa (United States) founded in 2002 by Edward P. It operates as a Licensing Model. Optigenex offers products and services including ac-11®. Optigenex operates in a competitive market with competitors including Amazentis, DecodeAge, Biote, Timeline and Nuchido, among others.
- Headquarter Melissa, United States
- Founders Edward P
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Optigenex Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$630 K (USD), Post-IPO
Nov 29, 2017
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Optigenex
Optigenex is a publicly listed company on the OTC with ticker symbol OPGX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Optigenex
Optigenex offers a comprehensive portfolio of products and services, including ac-11®.
Extract of Uncaria tomentosa supporting DNA repair naturally.
Funding Insights of Optigenex
Investments & Acquisitions by Optigenex
Investment portfolio details for Optigenex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Optigenex
Detailed financials for Optigenex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Optigenex Comparisons
Peer comparison for Optigenex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Optigenex
Optigenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amazentis, DecodeAge, Biote, Timeline and Nuchido, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developing nutritional products to slow aging and improve quality of life
|
|
| Locked | Locked | Locked |
Online platform offering drugs for longevity and age health
|
|
| Locked | Locked | Locked |
Hormone replacement and pellet therapy services are offered.
|
|
| Locked | Locked | Locked |
Clinically-tested Urolithin A supplements and skincare are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of dietary supplements
|
|
| Locked | Locked | Locked |
Anti-aging nutraceutical supplements are developed and tested.
|
Detailed competitors of Optigenex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Optigenex
Complete news archive for Optigenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optigenex
Optigenex was founded in 2002 and raised its 1st funding round 15 years after it was founded.
Optigenex is headquartered in Melissa, United States. It is registered at Melissa, Texas, United States.
Optigenex is engaged in developing patented, all-natural technologies for healthy aging, targeting the dietary supplement and skincare industries. Solutions are based on ac-11, a hot water extract of Uncaria tomentosa from the Amazon rainforest, aimed at supporting DNA repair. Research and sustainability are emphasized, with operations compliant with USDA, ISO 9002, FDA regulations, and GMP standards. Licensing opportunities are offered to manufacturers, distributors, and retailers worldwide.
Optigenex offers ac-11®.
Yes, Optigenex is publicly traded on OTC under the ticker symbol OPGX.
The ticker symbol of Optigenex is OPGX on OTC.